Keywords
transcatheter valves therapies
bicaval valve implantation
How to Cite
Abstract
Tricuspid regurgitation (TR) has shown great interest in recent years. Transcatheter endovascular procedures have acquired great relevance demonstrating to be a feasible therapy to improve the quality of life of these patients.
We report our experience implanting a bicaval valve prosthesis in an 85-year-old patient with severe symptomatic and inoperable TR.
A bicaval valve implantation (CAVI) in superior vena cava (SVC) and inferior vena cava (IVC) was performed. At the 2-month follow-up, a significant enhancement in NYHA functional class and quality of life was noted.
We believe these procedures are a feasible and safe option for patients experiencing severe heart failure with progressing symptoms and at high surgical risk. Long-term follow-up is still uncertain, and an improvement in survival should be demonstrated to be considered for lower-risk patients.
References
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004 Feb 4;43(3):405-9. https://doi.org/10.1016/j.jacc.2003.09.036. PMID: 15013122.
D'Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2019 Update on Outcomes and Quality. Ann Thorac Surg. 2019 Jan;107(1):24-32. https://doi.org/10.1016/j.athoracsur.2018.10.004. Epub 2018 Nov 10. PMID: 30423335.
Axtell AL, Bhambhani V, Moonsamy P, Healy EW, Picard MH, Sundt TM 3rd, et al. Surgery Does Not Improve Survival in Patients with Isolated Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2019 Aug 13;74(6):715-725. https://doi.org/10.1016/j.jacc.2019.04.028. Epub 2019 May 6. PMID: 31071413; PMCID: PMC8890054.
Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, et al. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair ?. JACC: Cardiovascular Interventions. 2017; 10:1982–1990. https://doi.org/10.1016/j.jcin.2017.08.011.
Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, Mizarien V, Codina P, Gual-Capllonch F, et al. Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation. J Clin Med. 2021 Oct 7;10(19):4601. https://doi.org/10.3390/jcm10194601. PMID: 34640619; PMCID: PMC8509289.
Lauten, A.; Doenst, T.; Hamadanchi, A.; Franz, M.; Figulla, H.R. Percutaneous Bicaval Valve Implantation for Transcatheter Treatment of Tricuspid Regurgitation. Circ. Cardiovasc. Interv. 2014, 7, 268–272.
Figulla HR et al. Treatment of Ticuspid Regurgitation with Heterotopic Transcutaneous Valve Implantations. CRT (Cardiovascular Research Technologies) Meeting, Washington, DC, February 26, 2013.
Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, Cruz-González I, Baz JA, Pascual I, et al. 6-Month Outcomes of the TricValve System in Patients with Tricuspid Regurgitation: The TRICUS EURO Study. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377. https://doi.org/10.1016/j.jcin.2022.05.022. Epub 2022 May 17. PMID: 35583363.